Linezolid Resistance in Staphylococci
Linezolid, the first oxazolidinone to be used clinically, is effective in the treatment of infections caused by various Gram-positive pathogens, including multidrug resistant enterococci and methicillin-resistant Staphylococus aureus. It has been used successfully for the treatment of patients with...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
MDPI
2010
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036669/ |
| Summary: | Linezolid, the first oxazolidinone to be used clinically, is effective in the treatment of infections caused by various Gram-positive pathogens, including multidrug resistant enterococci and methicillin-resistant Staphylococus aureus. It has been used successfully for the treatment of patients with endocarditis and bacteraemia, osteomyelitis, joint infections and tuberculosis and it is often used for treatment of complicated infections when other therapies have failed. |
|---|